• Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma Media

BioPharma Media

Biopharmaceutical industry analysis.
 Credible, reliable, equitable.

  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy

AstraZeneca

heart
Posted inClinical Trials, Metabolism

Merck & Co. Has Come Up With Very Powerful Pill Against ‘Bad’ Cholesterol

March 8, 2023March 8, 2023

MK-0616 is smashing all competitors for the prevention and treatment of atherosclerosis.

Dorzagliatin: Drug That Can “Cure” Diabetes
Posted inClinical Trials, Metabolism

Dorzagliatin: Drug That Can “Cure” Diabetes

November 13, 2022November 13, 2022

Hua Medicine has figured out how to bring type 2 diabetes mellitus into long-term and sustained remission.

Beyfortus: Effective Protection for Infants Against Respiratory Syncytial Virus
Posted inInfections, New Drugs, Regulatory

Beyfortus: Effective Protection for Infants Against Respiratory Syncytial Virus

September 17, 2022September 20, 2022

One injection of nirsevimab reliably protects newborns against the development of RSV-associated lower respiratory tract infections.

coronavirus Omicron
Posted inCOVID-19, Infections, Research

Omicron Treatment: Most Effective Drugs

August 31, 2022September 8, 2022

Efficacy of antivirals and monoclonal antibodies for outpatient treatment of COVID-19 infection with the Omicron variant of SARS-CoV-2 coronavirus.

weight-loss-pills
Posted inClinical Trials, In the Pipeline, Metabolism

Most Effective Weight Loss Drugs: Present and Future

July 3, 2022September 20, 2022

Modern pharmacological ways to combat obesity.

Evusheld: First Drug for Strong and Long-Lasting Protection Against Coronavirus
Posted inCOVID-19, Infections, New Drugs, Regulatory

Evusheld: First Drug for Strong and Long-Lasting Protection Against Coronavirus

June 8, 2022September 8, 2022

One dose of AstraZeneca’s monoclonal antibody cocktail protects against COVID-19 for six months or longer.

Mounjaro: New Dual-Action Drug for Type 2 Diabetes Mellitus
Posted inMetabolism, New Drugs, Regulatory

Mounjaro: New Dual-Action Drug for Type 2 Diabetes Mellitus

May 17, 2022September 8, 2022

Tirzepatide by Eli Lilly is a powerful new antidiabetic drug.

Posts navigation

1 2 3 Older posts
BioPharma Media Logo
Biopharmaceutical industry analysis.
© 2023 BioPharma Media. Newspack by Automattic. The end-to-end solution. Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News